U.S. Implantable Medical Devices Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


The global U.S. Implantable Medical Devices Market is estimated to be valued at US$ 19.27 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview:

Implantable medical devices provides medical support for diseased organs and tissue. These include pacemakers, stents, orthopedic implants and reconstructive joint implants. These devices improve patient quality of life and enhances treatment outcomes.

Market key trends:

One of the key trends driving the U.S. implantable medical devices market is the increasing demand for minimally invasive procedures and technologically advanced products. Minimally invasive surgeries are preferred by patients as they are less painful and enable faster recovery as compared to traditional open surgeries. Implantable medical devices manufacturers are developing technologically advanced products to offer enhanced accuracy, minimal invasiveness and improved clinical outcomes. For instance, 3D-printed implant technologies enable customization of implants as per patient's anatomy, which improves implantation accuracy and clinical outcomes. This is expected to significantly drive the demand for technologically advanced implantable devices. Growing preference for value-based healthcare is also leading to development of affordable and effective implantable devices targeting large patient pools in the U.S.

Read More @ https://www.coherentmarketinsights.com/market-insight/us-implantable-medical-devices-market-3853

Segment Analysis

The US implantable medical devices market is segmented into cardiovascular, neurostimulators, orthopedic, dental implants, and others. Among these, the cardiovascular segment dominates the market and accounted for over 35% market share in 2023. The high share of this segment is attributed to the increasing prevalence of heart diseases such as coronary heart disease, stroke, and heart attack in the US. As per the American Heart Association, cardiovascular disease has been the leading cause of death in the US, with over 805,000 Americans dying of heart disease, stroke or other cardiovascular diseases each year. 

Key Takeaways

The global U.S. implantable medical devices market is expected to witness high growth, exhibiting a CAGR of 6.1% over the forecast period, due to increasing prevalence of lifestyle diseases and chronic health conditions. 

Regional analysis

The Western region dominates the US implantable medical devices market with over 40% market share in 2023 due to presence of technologically advanced healthcare infrastructure and higher adoption of advanced medical devices. Texas is expected to grow at the fastest pace during the forecast period.

Key players 

Key players operating in the U.S. implantable medical devices market are Escalating Prevalence of Heart Diseases Propels Industry Growth, Technology innovation. Escalating prevalence of chronic diseases propels industry growth in the US. Favorable reimbursement policies and guidelines support the demand for implantable medical devices in the country. 

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

-
Image
A breast pump is a mechanical tool used by breastfeeding women to suction-extract their breast milk, which they then use to feed their newborn children. Both manually and electrically driven breast pumping equipment is available. Breast pumps are advantageous for working women, women with shorter gestational periods, and women who give birth to multiples since they are unable to simultaneously breastfeed all of the babies, therefore they prefer a breast pump. Breast pumps aid in meeting the nutritional needs of babies of working mothers who do not want to sacrifice their development and growth since they are not constantly present with their infants. Business Dynamics Launches of breast pumps by leading industry players are anticipated to fuel the market's expansion throughout the forecast period. For instance, Sonata, the first smart breast pump to give hospital-level performance in a personal use breast pump, was introduced by Madela, Inc. in November 2016. This breast pump conn...
Read more

Angioedema Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2024 To 2031

-
Image
Introduction: Angioedema, a condition characterized by rapid swelling of deeper layers of the skin and mucous membranes, poses a significant health concern for affected individuals. The Angioedema Treatment Market has been witnessing notable advancements, providing a ray of hope for patients grappling with this often unpredictable and potentially life-threatening condition. Market Dynamics: The Angioedema Treatment Market has experienced a paradigm shift in recent years, driven by increased awareness, improved diagnostic capabilities, and a surge in research and development efforts. Angioedema can be hereditary or acquired, and the market is witnessing a growing prevalence of both forms, necessitating a diversified approach to treatment options. Treatment Modalities: Therapeutic approaches to Angioedema have evolved, offering a range of options for patients. Antihistamines and corticosteroids are commonly prescribed for acute cases, providing relief from swelling and discomfort. In mor...
Read more